Antipsychotics in bipolar disorder

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 9, 1996, Pages 49-52

  Gelenberg, Alan J ^a   Hopkins, Heather S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; PIMOZIDE; RISPERIDONE;

BEHAVIOR DISORDER; CONFERENCE PAPER; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERACTIVITY; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MOTOR DYSFUNCTION; NEUROTOXICITY; PRIORITY JOURNAL; TARDIVE DYSKINESIA;

ACUTE DISEASE; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM; RISPERIDONE; TREATMENT OUTCOME;

EID: 0029822210     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Johnson G, Gershon S, Hekimian LJ. Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: an interim report. Compr Psychiatry 1968;9:563-573
2. Johnson G, Gerson S, Burdock EI, et al. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Br J Psychiatry 1971;119:267-276
3. Platman SR. A comparison of lithium carbonate and chlorpromazine in mania. Am J Psychiatry 1970;127:351-353
4. Spring G, Schweid D, Gray C, et al. A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. Am J Psychiatry 1970; 126:1306-1310
5. Takahashi R, Sakuma A, Itoh K, et al. Comparison of efficacy of lithium carbonate and chlorpromazine in mania: report of collaborative study group on treatment of mania in Japan. Arch Gen Psychiatry 1975;32:1310-1318
6. Prien RF, Caffey EM, Klett CJ. A comparison of lithium carbonate and chlorpromazine in the treatment of acute mania. Arch Gen Psychiatry 1972;26:146-153
7. Shopsin B, Gershon S, Thompson H, et al. Psychoactive drugs in mania: a controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry 1975;32:34-42
8. Post RM, Jimerson DC, Bunney WE Jr, et al. Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) 1980;67:297-305
9. Cookson JC, Silverstone T, Wells B. A double-blind controlled study of pimozide versus chlorpromazine in mania. Psychopharmacol Bull 1980; 16: 38-41
10. Janicak PG, Bresnahan DB, Sharma R, et al. A comparison of thiothixine with chlorpromazine in the treatment of mania. J Clin Psychopharmacol 1988;8:33-37
11. Rifkin A, Karajgi B, Doddi S, et al. Dose and blood levels of haloperidol in treatment of mania. Psychopharmacol Bull 1990;26:144-146
12. Kessel JB, Verghese C, Simpson GM. Neurotoxicity related to lithium and neuroleptic combinations? a retrospective review. J Psychiatry Neurosci 1992;17:28-30
13. Spring G, Frankel M. New data on lithium and haloperidol incompatibility. Am J Psychiatry 1981;138:818-821
14. McElroy SL, Dessain EC, Pope HG Jr, et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-414
15. Suppes T, McElroy SL, Gilbert J, et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992;32:270-280
16. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995;56:411-417
17. Kimmel SE, Calabrese JR, Woyshville MJ, et al. Clozapine in treatment-refractory mood disorders. J Clin Psychiatry 1994;55(9, suppl B):91-93
18. Calabrese JR, Meltzer HY, Markovitz PJ. Clozapine prophylaxis in rapid cycling bipolar disorder [letter]. J Clin Psychopharmacol 1991;11: 396-397
19. Tohen M, Zarate CA, Centorrino F, et al. Risperidone in the treatment of mania. Presented at the 35th annual meeting of the New Clinical Drug Evaluation Unit Program; May 31-June 3, 1995; Orlando, Fla
20. Singh AN, Catalan J. Risperidone in HIV-related manic psychosis [letter]. Lancet 1994;344:1029-1030
21. Goodnick PJ. Risperidone treatment of refractory acute mania [letter]. J Clin Psychiatry 1995;56:431-432
22. Madhusoodanan S, Brenner R, Araujo L, et al. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry 1995;56:514-518
23. Dwight MM, Keck PE Jr, Stanton SP, et al. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet 1994;344:554-555
24. Diaz SF. Mania associated with risperidone use [letter]. J Clin Psychiatry 1996;57:41-42
25. Hendrick V, Altshuler LL, Szuba MP. Is there a role for neuroleptics in bipolar depression? J Clin Psychiatry 1994;55:533-535
26. Sernyak MJ, Woods SW. Chronic neuroleptic use in manic-depressive illness [review]. Psychopharmacol Bull 1993;29:375-381
27. Sernyak MJ, Griffin RA, Johnson RM, et al. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-135
28. Licht RW, Gouliaev G, Vestergaard P, et al. Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. J Affect Disord 1994;32:179-185
29. Keck PE Jr, Wilson DR, Strakowski SM, et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995;56:466-470
30. Peselow ED, Fieve RR, Difiglia C, et al. Lithium prophylaxis of bipolar illness: the value of combination treatment. Br J Psychiatry 1994;164: 208-214
31. Naylor G, Scott C. Depot injections for affective disorders. Br J Psychiatry 1980;136:105
32. Ahlfors UG, Baastrup PC, Dencker SJ, et al. Flupenthixol decanoate in recurrent manic depressive illness. Acta Psychiatr Scand 1981;64: 226-237
33. Lowe M, Batchelor D. Depot neuroleptics and manic depressive psychosis. International Journal of Clinical Psychopharmacology 1986;1:53-62
34. Esparon J, Kalloor J, Naylor GJ, et al. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic depressive patients. Br J Psychiatry 1986;148:723-725
35. White E, Cheung P, Silverstone T. Depot antipsychotics in bipolar affective disorder. Int Clin Psychopharmacol 1993,8:119-122
36. Littlejohn R, Leslie F, Cookson J. Depot antipsychotics in the prophylaxis of bipolar affective disorder. Br J Psychiatry 1994;165:827-829
37. Steiner W, Laporta M, Chouinard G. Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder. Acta Psychiatr Scand 1990;81:437-440
38. Chouinard G, Jones BD. Schizophrenia as a dopamine-deficiency disease. Lancet 1978;328:99-100